abstract |
A combination of a 4-anilino-3-cyanoquinoline compound (e.g., HKI-272, SKI-606, EKB-569) and a capecitabine compound in neoplastic therapy is provided. Also provided are therapies, kits, and methods for the treatment of neoplasms, including breast cancer, including metastatic breast cancer, such as this combination, optionally with other anti-neoplastic agents or immunomodulators, and lung cancer. |